iifl-logo

Hemo Organic Ltd Board Meeting

10.9
(4.81%)
Jun 2, 2025|01:16:00 PM

Hemo Organic CORPORATE ACTIONS

02/06/2024calendar-icon
02/06/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting20 May 202516 May 2025
Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Tuesday 20th May 2025. Outcome of Board Meeting held on Tuesday, 20th May, 2025. (As Per BSE Announcement Dated on :20.05.2025)
Board Meeting31 Mar 202531 Mar 2025
Outcome of Board Meeting held today i.e., Monday, 31st March, 2025
Board Meeting6 Feb 20253 Feb 2025
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve 1. The Un-Audited Financial Results of the Company for the quarter and nine month ended as on 31st December 2024 along with Limited Review Report thereon. 2. To transact other businesses as per agenda being circulated The Board of Directors (the Board) at its meeting held on 6th February, 2025 commenced at 4.00 p.m. and concluded at 4:07 p.m., has approved and taken on record interalia: 1. The Un-Audited Financial Results (Standalone) for the quarter and nine months ended 31st December, 2024 prepared in terms of Regulation 33 of the SEBI Listing Regulations together with the Limited Review Report by the Statutory Auditors. (As Per BSE Announcement Dated on: 06/02/2025)
Board Meeting26 Dec 202420 Dec 2024
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/12/2024 inter alia to consider and approve 1. Issue of Equity shares of the Company on Rights basis. 2. To transact other businesses as per agenda being circulated. Outcome of Board Meeting held today i.e., 26th December, 2024 (As Per Bse Announcement Dated on 26.12.2024)
Board Meeting28 Oct 202423 Oct 2024
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve a) the Un-Audited Financial Results of the Company for the quarter and half year ended as on 30th September 2024 along with Limited Review Report thereon. b) To transact other businesses as per agenda being circulated. Outcome of Board Meeting held today i.e. on Monday, 28th October,2024 (As per BSE Announcement Dated on 28/10/2024)
Board Meeting14 Aug 20246 Aug 2024
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2024 as per Regulation 33 of the Listing Regulation and Any other item of business as may be decided by the board of directors of the company This is to inform you that the Board Meeting initially scheduled for today, Monday, August 12, 2024, has been postponed due to certain exigencies. The rescheduled meeting of the board of directors will be now held on Wednesday August 14, 2024 at 2:00 PM at the Registered office of the company (As Per BSE Announcement dated on 12.08.2024) Outcome of Board Meeting held today i.e., on Wednesday, August 14, 2024 (As Per BSE Announcement dated on 14.08.2024) Revised Outcome of Board meeting held today i.e. on Wednesday, August 14, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement dated on 17.08.2024)

Hemo Organic: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.